SAN FRANCISCO, June 3, 2020 /PRNewswire/ –The global cell expansion market size is expected to reach USD 39.7 billion by 2027 registering a CAGR of 9.4%, according to a new report by Grand View Research, Inc. Cell expansion techniques are increasingly employed for the development of cellular and gene therapies from a single cord blood collection. These techniques can also be used for the expansion of stored Stem Cells (SCs) for the development of cancer therapies. Therefore, significant developments in cord blood SCs expansion technologies are expected to boost market growth.
Key suggestions from the report:
- Broad portfolio of automated expansion systems along with improvements in bioreactor design for large-scale bioproduction results in the lucrative growth opportunity for instruments
- The microbial cells segment is expected to witness the fastest growth rate owing to the implementation of high-throughput cultivation approaches and techniques that avoid the formation of biofilms
- Biopharmaceuticals segment held the largest revenue share in 2019 due to growth in the demand for biosimilars, continuous R&D investments in biomanufacturing, and rise in the number of approvals for biologics
- Asia Pacific is anticipated to grow at the maximum CAGR from 2020 to 2027 due to presence of several consortiums that focus on the evolving fields in the biomedical industry
- For instance, in November 2019, the Cell & Gene Therapy Asia 2019 held in Japan focused on the evolving field of SCs for their deployment in pharmaceutical discovery and cellular therapies
Read 170 page research report with ToC on “Cell Expansion Market Size, Share & Trends Analysis Report By Product (Instruments, Consumables), By Cell Type (Mammalian, Animal), By Application, By End Use, And Segment Forecasts, 2020 – 2027” at: https://www.grandviewresearch.com/industry-analysis/cell-expansion-market
Companies have made heavy investments for the expansion of tissue-engineered products and the development of biologics. For instance, in March 2019, Merck KGaA invested USD 168 million for the expansion of its biologics manufacturing facility in Switzerland. Such initiatives are expected to boost the demand for solutions required for biologic development, thereby leading to market growth.
Bioreactors are fundamental tools in this market. Extensive research studies related to the applications of bioreactor engineering approaches have led to the incorporation of novel culture technologies. Moreover, the combined use of automated bioreactors with the microcarrier technology leads to an efficient expansion and enrichment of the cancer SCs. As a result, these approaches have gained immense traction in this market.
Grand View Research has segmented the global cell expansion market on the basis of product, cell type, application, end use, and region:
- Cell Expansion Product Outlook (Revenue, USD Million, 2016 – 2027)
- Consumables
- Reagents, Media, & Serum
- Other Consumables
- Culture Flasks and Accessories
- Tissue Culture Flasks
- Bioreactor Accessories
- Other Culture Flasks and Accessories
- Instruments
- Automated Cell Expansion Systems
- Cell Counters
- Centrifuges
- Bioreactors
- Other Instruments
- Cell Expansion Cell Type Outlook (Revenue, USD Million, 2016 – 2027)
- Mammalian
- Human
- Stem Cells (SCs)
- Adult SCs
- Embryonic SCs
- Induced Pluripotent SCs
- Differentiated Cells
- Animal
- Microbial
- Others
- Cell Expansion Application Outlook (Revenue, USD Million, 2016 – 2027)
- Biopharmaceuticals
- Tissue Culture & Engineering
- Vaccine Production
- Drug Development
- Gene Therapy
- Cancer Research
- Stem Cell Research
- Others
- Cell Expansion End-use Outlook (Revenue, USD Million, 2016 – 2027)
- Biopharmaceutical & Biotechnology Companies
- Research Institutes
- Cell Banks
- Others
- Cell Expansion Regional Outlook (Revenue, USD Million, 2016 – 2027)
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
- List of Key Companies of Cell Expansion Market
- Thermo Fisher Scientific, Inc.
- GE Healthcare
- Corning, Inc.
- STEMCELL Technologies, Inc.
- Merck KGaA
- Miltenyi Biotec
- Becton, Dickinson and Company
- Terumo Bct, Inc.
- Sartorius AG
- Takara Bio, Inc.
- Trinova Biochem GmbH
- upcyte technologies GmbH
Find more research reports on Biotechnology Industry, by Grand View Research:
- Clinical Oncology Next Generation Sequencing Market – Significant increase in the adoption of genome-focused pharmacology for cancer treatment is expected to provide growth avenues for the market.
- Short-read Sequencing Market – Accelerated demand for personalized medicine and companion diagnostics is anticipated to fuel the growth.
- Cell Sorting Market– Growing research in cell sorting technologies, technological advancements in cell sorters, and rising pharmaceutical & biotechnology companies are expected to drive growth.
Gain access to Grand View Compass, our BI enabled intuitive market research database of 10,000+ reports
About Grand View Research
Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: [email protected]
Web: https://www.grandviewresearch.com
Follow Us: LinkedIn | Twitter
SOURCE Grand View Research, Inc.
